European Union

Personalised healthcare is a complex concept. It will be best to chew on a mouthful at a time, while keeping an eye on the bigger picture.

A new initiative aims to develop computer and cell-based alternatives to animal toxicity testing, with the aim of replacing the use of one million animals each year in Europe.

Personalised medicine offers a way to prevent adverse reactions to drugs and avoid unnecessary treatments, but barriers are standing in the way.

Personalising medicine will improve healthcare and create important new markets. Europe needs to move now and seize the benefits it offers, writes Richard L. Hudson.

EU telecommunications ministers have unanimously approved the new Digital Agenda, even though only four were able to make it to Granada.

A European Court ruling on GM soy protein has implications for the patent rights of biotechs, say Nicholas Jones and Josie Zhou of the law firm Withers & Rogers LLP.

Can Europe build the world’s first low-carbon economy? The Commission has drafted an ambitious 10-year roadmap to invest in renewable energies.

67% of investment firms would reduce their investments if the proposed EU Alternative Investment Fund Managers Directive is implemented, says a new survey.

Gains in innovation performance up to 2008 may have been buried by the economic crisis according to the 2009 Innovation Scoreboard.

Despite the banking crisis, Iceland has maintained its top position in the innovation rankings published by the French business school INSEAD.